Associate Professor, Medicine, Tufts Medical Center
Gastroenterology
Dr. Daniel S. Matloff, MD
|
|
Give Review
Daniel Matloff practices Gastroenterology. He graduated from Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He has 2 awards "Fellow (AGAF)" and "Fellow (FACG)". Daniel Matloff is also published. He has 21 publications published. The lastest publication: "D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives.' Daniel S. Matloff accepts Medicare payments and is listed with Medicare.gov.
Publications
- Novel inflammatory biomarkers of portal pressure in compensated cirrhotic patients.
- Life-threatening acute airway obstruction in Achalasia.
- Propranolol for the prevention of first Esophageal variceal hemorrhage: a lifetime commitment?
- D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary Cirrhosis--successful treatment with plasmapheresis and immunosuppressives.
- Hepatic transaminase activity in alocholic liver Disease.
- Primary biliary cirrhosis and cold autoimmune hemolytic Anemia: effect of partial plasma exchange.
- Viral Hepatitis in homosexual men.
- Osteoporosis in primary biliary Cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
- A prospective trial of D-penicillamine in primary biliary Cirrhosis.
- Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary Cirrhosis.
- Evidence against an immune complex pathogenesis of primary biliary Cirrhosis.
- gamma-Glutamyl transpeptidase activity in liver Disease: serum elevation is independent of hepatic GGTP activity.
- Propranolol in the prevention of the first hemorrhage from esophagogastric Varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hyp...
- Treatment of acute variceal Bleeding.
- Obesity is an independent risk factor for clinical decompensation in patients with Cirrhosis.
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of Cirrhosis.
- Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated Cirrhosis.
- Platelet count is not a predictor of the presence or development of gastroesophageal varices in Cirrhosis.
- Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated Cirrhosis.
- Beta-blockers to prevent gastroesophageal varices in patients with Cirrhosis.
Schools
Tufts University School Of Medicine
New Eng Med Center Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow (AGAF)
- Fellow (FACG)
Education
-
Tufts Medical Center -
Tufts University School of Medicine
Hospital
-
Brigham and Women's Hospital -
Brigham and Women's Faulkner Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Benjamin N. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ewa M. Preneta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward A. Lew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Hermos, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Stephen C. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Drewniak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muthoka L. Mutinga, MD
This Doctor is OpenDoctor Recommended.
|